Research Summary Drugs and Diagnostics for parasitic diseases of poverty Parasitic diseases associated with poverty, including the neglected tropical diseases, are overlooked in terms of the number, efficacy and safety of the drugs available for treatment. As part of the Center for Discovery and Innovation in Parasitic Diseases (CDIPD), and with a focus on schistosomiasis, African trypanosomiasis and hookworm disease, three broad themes underpin my team’s research: (1) the identification and validation of protein targets for drug development; (2) the pre-clinical and translational development of drugs, including the development and application of associated technologies (high-content and high-throughput screening platforms, Machine Learning, protein expression and animal models of infection); and (3) the development of point-of care (POC) diagnostics. To facilitate our cross-disciplinary research interests, my team collaborates with academia and the pharmaceutical industry worldwide, including with bioinformaticians, medicinal and clinical chemists, structural biologists and automated systems specialists. Finally, with international partners, my team is actively engaged in training and capacity-building with researchers from low-/middle-income countries to translate drug discovery practices and technologies back to their home institutions.